0001593968-23-001469.txt : 20231129 0001593968-23-001469.hdr.sgml : 20231129 20231129142903 ACCESSION NUMBER: 0001593968-23-001469 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231128 FILED AS OF DATE: 20231129 DATE AS OF CHANGE: 20231129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HO WILLIAM CENTRAL INDEX KEY: 0001400901 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38997 FILM NUMBER: 231451116 MAIL ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RAPT Therapeutics, Inc. CENTRAL INDEX KEY: 0001673772 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473313701 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 489-9000 MAIL ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FLX Bio, Inc. DATE OF NAME CHANGE: 20160504 4 1 primary_01.xml PRIMARY DOCUMENT X0508 4 2023-11-28 0001673772 RAPT Therapeutics, Inc. RAPT 0001400901 HO WILLIAM C/O RAPT THERAPEUTICS, INC., 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 false true false false Chief Medical Officer false Common Stock 2023-11-28 4 S false 1500 13.72 D 17520 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person on October 17, 2022. Includes 231 shares acquired by Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on October 31, 2023. /s/ Rodney Young, Attorney-in-Fact for William Ho 2023-11-29